Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
All anabolic steroids suppress natural testosterone production. However, the rate of suppression often varies greatly from one steroid to the next. Although it does suppress natural testosterone production, Primobolan’s rate of suppression is much less dramatic than many anabolic steroids. In a therapeutic plan, it is actually possible to keep the total rate of suppression below 50%. This could be low enough to keep some from falling into a low level condition despite the reduction. However, performance level doses will be another story. Dramatic suppression is all but assured with such doses making the inclusion of exogenous testosterone extremely important. Men who do not include exogenous testosterone will more than likely fall into a low testosterone condition. Not only does this carry numerous possible bothersome symptoms, it is extremely unhealthy. Women, despite needing testosterone will not have a need for exogenous therapy when using Primobolan.
Once the use of Primo and all anabolic steroids has come to an end, natural testosterone production will begin again. You will find this is one of the easiest steroids to recover from when it comes to testosterone production. Most men are encouraged to implement a Post Cycle Therapy (PCT) plan once use is discontinued. This will speed the recovery process up. It will, however, not return you to normal on its own. This will still take time. However, a PCT plan will ensure you have enough testosterone for proper bodily function while your levels continue to naturally rise. Those who do not implement a PCT plan, while they may recover it will take far longer. There’s really no reason to forgo the PCT process if you’re going to be off cycle for any decent length of time.
An important note on natural testosterone recovery. Natural recovery assumes no prior low testosterone condition existed. It also assumes severe damage was not done to the Hypothalamic-Pituitary-Testicular-Axis (HPTA) through improper steroidal supplementation practices.
A two- to four-fold increase in relative risk of post-operative thromboembolic complications has been reported with the use of oral contraceptives (9, 26). The relative risk of venous thrombosis in women who have predisposing conditions is twice that of women without such medical conditions (9, 26). If feasible, oral contraceptives should be discontinued at least four weeks prior to and for two weeks after elective surgery of a type associated with an increase in risk of thromboembolism and during and following prolonged immobilization. Since the immediate postpartum period is associated with an increased risk of thromboembolism, oral contraceptives should be started no earlier than four weeks after delivery in women who elect not to breast feed.